Cargando…

Structural basis for exploring the allosteric inhibition of human kidney type glutaminase

Cancer cells employ glutaminolysis to provide a source of intermediates for their upregulated biosynthetic needs. Glutaminase, which catalyzes the conversion of glutamine to glutamate, is gaining increasing attention as a potential drug target. Small-molecule inhibitors such as BPTES and CB-839, whi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ramachandran, Sarath, Pan, Catherine Qiurong, Zimmermann, Sarah C., Duvall, Bridget, Tsukamoto, Takashi, Low, Boon Chuan, Sivaraman, J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295402/ https://www.ncbi.nlm.nih.gov/pubmed/27462863 http://dx.doi.org/10.18632/oncotarget.10791

Ejemplares similares

Structural Basis for the Active Site Inhibition Mechanism of Human Kidney-Type Glutaminase (KGA)
por: Thangavelu, K., et al.
Publicado: (2014)

Allosteric Glutaminase Inhibitors Based on a 1,4-Di(5-amino-1,3,4-thiadiazol-2-yl)butane Scaffold
por: Zimmermann, Sarah C., et al.
Publicado: (2016)

Self-Assembled Micellar Glutaminase Allosteric Inhibitor for Effective Therapeutic Intervention
por: Fang, Jinzhang, et al.
Publicado: (2022)

Upregulation of the Glutaminase II Pathway Contributes to Glutamate Production upon Glutaminase 1 Inhibition in Pancreatic Cancer
por: Udupa, Sunag, et al.
Publicado: (2019)

Dendrimer-conjugated glutaminase inhibitor selectively targets microglial glutaminase in a mouse model of Rett syndrome
por: Khoury, Elizabeth Smith, et al.
Publicado: (2020)

Targeting glutaminase and mTOR
por: Tanaka, Kazuhiro, et al.
Publicado: (2015)

Topography induces differential sensitivity on cancer cell proliferation via Rho-ROCK-Myosin contractility
por: Chaudhuri, Parthiv Kant, et al.
Publicado: (2016)

Glutaminase inhibition in renal cell carcinoma therapy
por: Raczka, Aleksandra M., et al.
Publicado: (2019)

The Structural Basis of ATP as an Allosteric Modulator
por: Lu, Shaoyong, et al.
Publicado: (2014)

The oncogenic transcription factor c-Jun regulates glutaminase expression and sensitizes cells to glutaminase-targeted therapy
por: Lukey, Michael J., et al.
Publicado: (2016)

Q-ing tumor glutaminase therapy
por: Stine, Zachary E., et al.
Publicado: (2015)

Governing glutaminolysis by regulation of glutaminase succinylation
por: Ma, Qingxia, et al.
Publicado: (2021)

The Role of Glutamine and Glutaminase in Pulmonary Hypertension
por: Wang, Shang, et al.
Publicado: (2022)

Targeting glutaminase to starve lymphoma cells
por: Dumontet, Charles
Publicado: (2022)

Glutaminase Inhibition on NSCLC Depends on Extracellular Alanine Exploitation
por: Caiola, Elisa, et al.
Publicado: (2020)

Effect of glutaminase inhibition on cancer-induced bone pain
por: Fazzari, Jennifer, et al.
Publicado: (2019)

Kir4.2 mediates proximal potassium effects on glutaminase activity and kidney injury
por: Terker, Andrew S., et al.
Publicado: (2022)

Simulating EGFR-ERK Signaling Control by Scaffold Proteins KSR and MP1 Reveals Differential Ligand-Sensitivity Co-Regulated by Cbl-CIN85 and Endophilin
por: Huang, Lu, et al.
Publicado: (2011)

Metabolic modulation of neurogenesis: Role of glutaminase-2
por: Salomoni, Paolo
Publicado: (2014)

Targeting hepatic glutaminase activity to ameliorate hyperglycemia
por: Miller, Russell A., et al.
Publicado: (2018)

Safety assessment of glutaminase from Aspergillus niger
por: Vo, Trung Duc, et al.
Publicado: (2020)

Identification and characterization of a novel glutaminase inhibitor
por: Cederkvist, Henning, et al.
Publicado: (2021)

Metformin Inhibits Glutaminase Activity and Protects against Hepatic Encephalopathy
por: Ampuero, Javier, et al.
Publicado: (2012)

Tumor-suppressive function of EZH2 is through inhibiting glutaminase
por: Liu, Yongfeng, et al.
Publicado: (2021)

Kidney-type glutaminase (GLS1) is a biomarker for pathologic diagnosis and prognosis of hepatocellular carcinoma
por: Yu, Decai, et al.
Publicado: (2015)

Kidney-type glutaminase is a biomarker for the diagnosis and prognosis of hepatocellular carcinoma: a prospective study
por: Zhang, Laizhu, et al.
Publicado: (2023)

Binding Leverage as a Molecular Basis for Allosteric Regulation
por: Mitternacht, Simon, et al.
Publicado: (2011)

High-resolution structures of mitochondrial glutaminase C tetramers indicate conformational changes upon phosphate binding
por: Nguyen, Thuy-Tien T., et al.
Publicado: (2022)

Serial deletion reveals structural basis and stability for the core enzyme activity of human glutaminase 1 isoforms: relevance to excitotoxic neurodegeneration
por: Li, Yuju, et al.
Publicado: (2017)

Glutaminase inhibition in multiple myeloma induces apoptosis via MYC degradation
por: Effenberger, Madlen, et al.
Publicado: (2017)

Glutamine to proline conversion is associated with response to glutaminase inhibition in breast cancer
por: Grinde, Maria T., et al.
Publicado: (2019)

Glutaminase-1 (GLS1) inhibition limits metastatic progression in osteosarcoma
por: Ren, L., et al.
Publicado: (2020)

Aspirin reprogrammes colorectal cancer cell metabolism and sensitises to glutaminase inhibition
por: Holt, Amy K., et al.
Publicado: (2023)

The Biological and Clinical Significance of Glutaminase in Luminal Breast Cancer
por: Masisi, Brendah K., et al.
Publicado: (2021)

Structural basis for GPR40 allosteric agonism and incretin stimulation
por: Ho, Joseph D., et al.
Publicado: (2018)

Structural basis of allosteric regulation of Tel1/ATM kinase
por: Xin, Jiyu, et al.
Publicado: (2019)

Structural basis for allosteric regulation of Human Topoisomerase IIα
por: Vanden Broeck, Arnaud, et al.
Publicado: (2021)

Inhibiting glutaminase in acute myeloid leukemia: metabolic dependency of selected AML subtypes
por: Matre, Polina, et al.
Publicado: (2016)

Environmental cystine drives glutamine anaplerosis and sensitizes cancer cells to glutaminase inhibition
por: Muir, Alexander, et al.
Publicado: (2017)

Targeting Endothelial Cell Metabolism by Inhibition of Pyruvate Dehydrogenase Kinase and Glutaminase-1
por: Schoonjans, Céline A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_u1dmdjuptlk5cmlk7h2f9e79lv